• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异柠檬酸脱氢酶 1 突变的解剖定位:146 例低级别胶质瘤的基于体素的放射影像学研究。

Anatomical localization of isocitrate dehydrogenase 1 mutation: a voxel-based radiographic study of 146 low-grade gliomas.

机构信息

Beijing Neurosurgical Institute, Capital Medical University, Beijing, China; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

出版信息

Eur J Neurol. 2015 Feb;22(2):348-54. doi: 10.1111/ene.12578. Epub 2014 Oct 16.

DOI:10.1111/ene.12578
PMID:25318355
Abstract

BACKGROUND AND PURPOSE

A brain tumor's location is associated with the genetic profile of its tumor precursor cells. Mutations in isocitrate dehydrogenase 1 (IDH1) are an early event in tumor development and play a critical role in gliomagenesis. This study was conducted to specify the anatomical characteristics of IDH1 mutation in low-grade gliomas and to further explore the origin of gliomas with IDH1 mutation. The impact of IDH1 mutation on disease prognosis was also evaluated.

METHODS

The pre-operative magnetic resonance images obtained from 146 patients with histologically confirmed low-grade glioma were analyzed retrospectively. All tumors were manually marked and registered to the standard location. Voxel-based lesion-symptom mapping analysis was used to identify brain regions associated with a high occurrence of IDH1 mutation. Progression-free survival and overall survival were estimated using the Kaplan-Meier method, and potential prognostic factors were evaluated using the multivariate proportional hazards model.

RESULTS

Isocitrate dehydrogenase 1 mutated low-grade gliomas occurred most frequently in the frontal lobe, and specifically in the area surrounding the rostral extension of the lateral ventricles. Additionally, it was demonstrated that IDH1 mutation was an independent predictor for longer progression-free survival and overall survival.

CONCLUSIONS

Low-grade gliomas with IDH1 mutation are region-specific and preferentially located surrounding the rostral extension of the lateral ventricles. Furthermore, such mutations are associated with a favorable clinical outcome.

摘要

背景与目的

脑瘤的位置与肿瘤前体细胞的基因谱有关。异柠檬酸脱氢酶 1(IDH1)突变是肿瘤发生的早期事件,在神经胶质瘤发生中起着关键作用。本研究旨在明确 IDH1 突变在低级别胶质瘤中的解剖特征,并进一步探讨 IDH1 突变型胶质瘤的起源。同时评估 IDH1 突变对疾病预后的影响。

方法

回顾性分析 146 例经组织学证实的低级别胶质瘤患者的术前磁共振图像。手动标记所有肿瘤并注册到标准位置。采用基于体素的病变-症状映射分析识别 IDH1 突变高发生率相关的脑区。使用 Kaplan-Meier 法估计无进展生存率和总生存率,并使用多变量比例风险模型评估潜在的预后因素。

结果

IDH1 突变的低级别胶质瘤最常发生于额叶,特别是侧脑室额角延伸区域周围。此外,研究表明 IDH1 突变是无进展生存率和总生存率延长的独立预测因素。

结论

IDH1 突变的低级别胶质瘤具有特定的区域分布特征,优先发生于侧脑室额角延伸区域周围。此外,此类突变与良好的临床预后相关。

相似文献

1
Anatomical localization of isocitrate dehydrogenase 1 mutation: a voxel-based radiographic study of 146 low-grade gliomas.异柠檬酸脱氢酶 1 突变的解剖定位:146 例低级别胶质瘤的基于体素的放射影像学研究。
Eur J Neurol. 2015 Feb;22(2):348-54. doi: 10.1111/ene.12578. Epub 2014 Oct 16.
2
Anatomical location differences between mutated and wild-type isocitrate dehydrogenase 1 in low-grade gliomas.低级别胶质瘤中突变型和野生型异柠檬酸脱氢酶1的解剖学位置差异
Int J Neurosci. 2017 Oct;127(10):873-880. doi: 10.1080/00207454.2016.1270278. Epub 2017 Jan 6.
3
Subgroup characteristics of insular low-grade glioma based on clinical and molecular analysis of 42 cases.基于42例岛叶低级别胶质瘤临床及分子分析的亚组特征
J Neurooncol. 2016 Feb;126(3):499-507. doi: 10.1007/s11060-015-1989-5. Epub 2015 Nov 19.
4
Patterns of Tumor Contrast Enhancement Predict the Prognosis of Anaplastic Gliomas with IDH1 Mutation.肿瘤对比增强模式可预测 IDH1 突变的间变性胶质瘤的预后。
AJNR Am J Neuroradiol. 2015 Nov;36(11):2023-9. doi: 10.3174/ajnr.A4407. Epub 2015 Aug 27.
5
Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.异柠檬酸脱氢酶1第132位密码子突变是神经胶质瘤中一种重要的预后生物标志物。
J Clin Oncol. 2009 Sep 1;27(25):4150-4. doi: 10.1200/JCO.2009.21.9832. Epub 2009 Jul 27.
6
Brain T1ρ mapping for grading and IDH1 gene mutation detection of gliomas: a preliminary study.脑 T1ρ 图谱在胶质瘤分级和 IDH1 基因突变检测中的应用:一项初步研究。
J Neurooncol. 2019 Jan;141(1):245-252. doi: 10.1007/s11060-018-03033-7. Epub 2018 Nov 9.
7
Isocitrate dehydrogenase 1 Gene Mutation Is Associated with Prognosis in Clinical Low-Grade Gliomas.异柠檬酸脱氢酶1基因突变与临床低级别胶质瘤的预后相关。
PLoS One. 2015 Jun 26;10(6):e0130872. doi: 10.1371/journal.pone.0130872. eCollection 2015.
8
IDH1 status is significantly different between high-grade thalamic and superficial gliomas.异柠檬酸脱氢酶1(IDH1)状态在高级别丘脑胶质瘤和浅表性胶质瘤之间存在显著差异。
Cancer Biomark. 2017 Aug 23;20(2):183-189. doi: 10.3233/CBM-170175.
9
Imaging growth and isocitrate dehydrogenase 1 mutation are independent predictors for diffuse low-grade gliomas.影像学生长情况和异柠檬酸脱氢酶1突变是弥漫性低级别胶质瘤的独立预测因素。
Neuro Oncol. 2014 Aug;16(8):1100-9. doi: 10.1093/neuonc/nou085. Epub 2014 May 20.
10
Prognostic impact of the isocitrate dehydrogenase 1 single-nucleotide polymorphism rs11554137 in malignant gliomas.异柠檬酸脱氢酶 1 单核苷酸多态性 rs11554137 对恶性胶质瘤的预后影响。
Cancer. 2013 Feb 15;119(4):806-13. doi: 10.1002/cncr.27798. Epub 2012 Nov 26.

引用本文的文献

1
Targeting Isocitrate Dehydrogenase (IDH) in Solid Tumors: Current Evidence and Future Perspectives.靶向实体瘤中的异柠檬酸脱氢酶(IDH):当前证据与未来展望
Cancers (Basel). 2024 Aug 2;16(15):2752. doi: 10.3390/cancers16152752.
2
The involvement of brain regions associated with lower KPS and shorter survival time predicts a poor prognosis in glioma.与较低的 Karnofsky 功能状态评分(KPS)和较短生存时间相关的脑区受累预示着胶质瘤的预后不良。
Front Neurol. 2023 Dec 4;14:1264322. doi: 10.3389/fneur.2023.1264322. eCollection 2023.
3
Prognostic Factors and Resectability Predictors in Insular Gliomas: A Systematic Review.
岛叶胶质瘤的预后因素和可切除性预测因素:系统评价。
J Neurol Surg A Cent Eur Neurosurg. 2024 Jan;85(1):74-87. doi: 10.1055/s-0043-1769128. Epub 2023 Aug 24.
4
New insights into glioma frequency maps: From genetic and transcriptomic correlate to survival prediction.脑胶质瘤频率图谱的新见解:从遗传和转录组相关性到生存预测。
Int J Cancer. 2023 Mar 1;152(5):998-1012. doi: 10.1002/ijc.34336. Epub 2022 Nov 24.
5
Noninvasive Determination of the IDH Status of Gliomas Using MRI and MRI-Based Radiomics: Impact on Diagnosis and Prognosis.使用 MRI 和基于 MRI 的放射组学无创测定脑胶质瘤 IDH 状态:对诊断和预后的影响。
Curr Oncol. 2022 Sep 23;29(10):6893-6907. doi: 10.3390/curroncol29100542.
6
Preoperative Diagnosis and Molecular Characterization of Gliomas With Liquid Biopsy and Radiogenomics.基于液体活检和放射基因组学的胶质瘤术前诊断及分子特征分析
Front Neurol. 2022 May 26;13:865171. doi: 10.3389/fneur.2022.865171. eCollection 2022.
7
Lesion covariance networks reveal proposed origins and pathways of diffuse gliomas.病变协方差网络揭示了弥漫性胶质瘤的推测起源和途径。
Brain Commun. 2021 Dec 4;3(4):fcab289. doi: 10.1093/braincomms/fcab289. eCollection 2021.
8
The reliability and interobserver reproducibility of T2/FLAIR mismatch in the diagnosis of IDH-mutant astrocytomas.T2/FLAIR 不匹配对 IDH 突变型星形细胞瘤诊断的可靠性和观察者间可重复性。
Diagn Interv Radiol. 2021 Nov;27(6):796-801. doi: 10.5152/dir.2021.20624.
9
Lower-Grade Gliomas: An Epidemiological Voxel-Based Analysis of Location and Proximity to Eloquent Regions.低级别胶质瘤:基于体素的位置及与功能区接近程度的流行病学分析
Front Oncol. 2021 Sep 21;11:748229. doi: 10.3389/fonc.2021.748229. eCollection 2021.
10
Advanced Imaging and Computational Techniques for the Diagnostic and Prognostic Assessment of Malignant Gliomas.高级影像学和计算技术在恶性脑胶质瘤的诊断和预后评估中的应用。
Cancer J. 2021;27(5):344-352. doi: 10.1097/PPO.0000000000000545.